DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epogen (Epoetin Alfa) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epogen (Epoetin Alfa) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Epogen side effects in 46 year old female

Reported by a physician from United States on 2012-07-04

Patient: 46 year old female

Reactions: Therapeutic Response Decreased, Refractory Anaemia, Bone Marrow Failure, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epogen
    Dosage: 20000 iu, 3 times/wk
    Indication: Renal Failure Chronic
    Start date: 2008-10-31

Epogen



Possible Epogen side effects in 46 year old female

Reported by a physician from United States on 2012-06-01

Patient: 46 year old female

Reactions: Therapeutic Response Decreased, Refractory Anaemia, Myelodysplastic Syndrome, Bone Marrow Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epogen



Possible Epogen side effects in 46 year old female

Reported by a physician from United States on 2012-05-30

Patient: 46 year old female

Reactions: Therapeutic Response Decreased, Refractory Anaemia, Myelodysplastic Syndrome, Bone Marrow Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epogen



Possible Epogen side effects in 46 year old female

Reported by a physician from United States on 2012-05-30

Patient: 46 year old female

Reactions: Therapeutic Response Decreased, Refractory Anaemia, Bone Marrow Failure, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epogen



Possible Epogen side effects in 46 year old female

Reported by a physician from United States on 2012-05-14

Patient: 46 year old female

Reactions: Refractory Anaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Epogen



Possible Epogen side effects in 55 year old female

Reported by a physician from United States on 2012-03-08

Patient: 55 year old female

Reactions: Pulse Abnormal, Vomiting, Pruritus, Piloerection, Hypersensitivity, Dyspnoea, Nausea, Cardio-Respiratory Arrest, Chest Pain, Sneezing, Blood Pressure Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epogen
    Dosage: 5500 iu, 3 times/wk
    Indication: Renal Failure Chronic
    Start date: 2012-01-21

Epogen
    Dosage: 5500 iu, 3 times/wk
    Start date: 2012-01-21

Epogen
    Dosage: 4400 iu, 3 times/wk

Epogen
    Dosage: 3300 iu, 3 times/wk
    Start date: 2011-12-29



Possible Epogen side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30

Patient: 55 year old female

Reactions: Pulse Abnormal, Vomiting, Dyspnoea, Piloerection, Hypersensitivity, Pruritus, Nausea, Cardio-Respiratory Arrest, Chest Pain, Sneezing, Blood Pressure Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epogen
    Dosage: 5500 iu, 3 times/wk
    Indication: Renal Failure Chronic
    Start date: 2012-01-21

Epogen
    Dosage: 3300 iu, 3 times/wk
    Start date: 2011-12-29

Epogen
    Dosage: 4400 iu, 3 times/wk

Epogen
    Dosage: 5500 iu, 3 times/wk
    Start date: 2012-01-21



Possible Epogen side effects in 54 year old female

Reported by a physician from United States on 2011-11-17

Patient: 54 year old female, weighing 69.4 kg (152.7 pounds)

Reactions: Pancytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Interferon
    Dosage: 96 mcg;qw;sc
    Start date: 2010-06-16

Interferon
    Dosage: 96 mcg;qw;sc
    Start date: 2010-08-17
    End date: 2010-10-16

Interferon
    Dosage: 96 mcg;qw;sc
    Start date: 2010-07-26

Boceprevir
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-08-17
    End date: 2010-10-16

Boceprevir
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-06-16

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-08-17
    End date: 2010-10-16

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-06-16

Epogen
    Dosage: ;qw; sc
    Indication: Anaemia
    Start date: 2010-08-17
    End date: 2010-10-16

Epogen
    Dosage: ;qw; sc
    Indication: Anaemia
    Start date: 2010-06-16

Other drugs received by patient: Extra Strength Tylenol PM; Aveeno / 00302501 /; Tylenol (Caplet); Acetaminophen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017